Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00691743
Other study ID # NIS-GGR-DUM-2008/1
Secondary ID
Status Completed
Phase N/A
First received June 3, 2008
Last updated January 9, 2009
Start date March 2008
Est. completion date December 2008

Study information

Verified date January 2009
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Greece: National Organization of Medicines
Study type Observational

Clinical Trial Summary

The current epidemiological study will be undertaken in GP's and specialized private doctors. In total, 85 general practitioners, orthopedics, rheumatologists and cardiologist will take part in the study. Data will be collected for 850 patients who visit their physician for medical conditions that require the use of acetylsalicylic acid and/or NSAIDS. The first 10 consecutive patients who visit their GP/orthopedic/rheumatologist/cardiologists and are currently receiving acetylsalicylic acid and/or NSAIDS will be included in the study.


Recruitment information / eligibility

Status Completed
Enrollment 850
Est. completion date December 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Acetylsalicylic acid/NSAIDS intake for at least 5 days of a week during the past month before the patient's visit to the clinician

Exclusion Criteria:

- Patients who are not willing to sign of the Informed Consent Form

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Greece Research Site Agrinio
Greece Research Site Alexandroupoli
Greece Research Site Argostoli
Greece Research Site Athens
Greece Research Site Chalkida
Greece Research Site Drama
Greece Research Site Heraklion
Greece Research Site Ioannina
Greece Research Site Kalamata
Greece Research Site Kallikratia
Greece Research Site Katerini
Greece Research Site Kiato
Greece Research Site Komotini
Greece Research Site Korinthos
Greece Research Site Kozani
Greece Research Site Lamia
Greece Research Site Larisa
Greece Research Site Patra
Greece Research Site Peireous
Greece Research Site Pirgos
Greece Research Site Preveza
Greece Research Site Rethimnon
Greece Research Site Serres
Greece Research Site Thessaloniki
Greece Research Site Tripoli
Greece Research Site Volos
Greece Research Site Xania

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency (%) of patients in the Greek Primary Practice, presenting Upper GI Symptoms while receiving NSAIDS treatment with/without gastroprotective measures. Single visit / once
Secondary The nature of upper GI symptoms (Dyspepsia and GERD) experienced by patients receiving acetylsalicylic acid and / or NSAIDS treatment single visit / once
Secondary To determine the main indications for acetylsalicylic acid and or NSAIDS prescription among GPs and specialized private doctors in Greece. single visit / once